Literature DB >> 25186484

[Regression of primary rectal MALT lymphoma after Helicobacter pylori eradication].

Kisato Nosaka1, Takashi Shono, Yuji Yonemura, Ken-Ichi Iyama, Yutaka Sasaki, Shinya Endo, Yutaka Okuno, Hiroaki Mitsuya.   

Abstract

A 74-year-old-man was referred to our hospital to undergo examination and therapy for a rectal polypoid lesion. MALT lymphoma of the rectum (stage IE) was diagnosed by performing a biopsy of the tumor during colonoscopy. The patient received eradication therapy against Helicobacter pylori (H. pylori) because of chronic gastritis due to H. pylori, and a complete remission was documented after this therapy. However, MALT lymphoma recurred 18 months later. Our observations in this case suggest that eradication therapy against H. pylori may be useful not only for gastric MALT lymphoma but also for colorectal MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25186484

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

1.  Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017.

Authors:  Jae Hee Won; Sung Min Kim; Jong Wan Kim; Jun Ho Park; Jeong Yeon Kim
Journal:  Cancer Manag Res       Date:  2019-09-20       Impact factor: 3.989

2.  Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes.

Authors:  Shigenobu Watanabe; Ichiro Ogino; Masaharu Hata
Journal:  Blood Res       Date:  2020-12-31

3.  Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma.

Authors:  Tomoko Miyata-Takata; Katsuyoshi Takata; Tomohiro Toji; Naoe Goto; Senji Kasahara; Takeshi Takahashi; Akira Tari; Mai Noujima-Harada; Takafumi Miyata; Yasuharu Sato; Tadashi Yoshino
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.